Indraprastha Medical FY26 Net Profit Rises 14% to ₹183.62 Cr

Board approved audited financial results for FY26 with revenue of ₹1,482.51 crore and net profit of ₹183.62 crore, up 14% year-on-year.
Recommended dividend of ₹4.00 per share (40%) for FY25-26, subject to shareholder approval at upcoming AGM.
Auditors issued unmodified opinion on financial results, confirming compliance with accounting standards and SEBI regulations.
Company confirmed it does not qualify as a Large Corporate under SEBI circulars and operates solely in healthcare segment.